REFERENCES
- Adler I.D., Ramarao G. and Epstein S.S., 1971.—In vivo cytogenetic effects of trimethylphosphate and of TEPA on bone marrow cells of male rats. Mutation Res., 13: 263–273.
- Anantha Reddy G. and Subramanyam S., 1978.—Action of paracetamol on dividing cells of Allium cepa. Curr. Sci., 47: 20–22.
- Anantha Reddy G. and Subramanyam S., 1981a.—Cytogenetic effects of Amidopyrine + Allobarbitone on in vivo somatic cells of mice. IRCS Med. Sci., 9: 1139–1140.
- Anantha Reddy G. and Subramanyam S., 1981b.—Response of mitotic cells of Allium cepa to paracetamol. In: «Perspectives in Cytology and Genetics». (eds. G.K. Manna and U. Sinha), Hindasia Publishers, New Delhi, 3: 571–576.
- Anantha Reddy G., 1982.—Induction of meiotic non-disjunction by analgesic and antipyretic drugs in male mice. J. Bio. Res., 2: 126–131.
- Anantha Reddy G.. 1983.—Cytogenetic effects of metamizole on in vivo bone marrow cells of mice. Caryologia, 36: 385–392.
- Anonymous, 1975.—Principles for evaluating chemical in environment. U.S. National Academy of Sciences, Washington D.C.
- Bishun N.P., Williams D.C., Mills J., Lloyd N. Raven R.W. and Parke D.V., 1973.—Chromosome damage induced by chemicals. Chem. Biol. Interact., 6: 375–392.
- Davidson A.R., Rodas-Bueno A., Thompson R.P.H. and Williams R., 1976.—Early unconjugated hyperbilirubinomia after paracetamol over dose. Scad. j. Gastroent., 11: 623–628.
- Deknudt GH., Colle A. and Gerner G.B., 1977.—Chromosomal abnormalties in lymphocytes from monkeys poisoned with lead. Mutation Res., 45: 77–83.
- Evans H.J. and O'riordan M.L., 1975.—Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. Mutation Res., 31: 135–148.
- Gebhardt E., 1971.—Experimentalle Beitrage zum Problem der lokalen Achromasien (Gaps). Humangenetik, 13: 9.
- Green S., Saurd F.M. and Legator M.S., 1973.—Cytogenetic effects of hycanthone in the rat. Mutation Res., 17: 239–244.
- Kilian D.J., Morelandfe M., Benge M.C., Elgator M.S. and Whorton JR., 1977.—A collaborative study to measure interlaboratory variation using in vivo bone marrow metaphase procedure. In: «Handbook of mutagenicity test procedure» (eds. B.J. Killey, M.S. Legator, W. Nichols and C. Ramel), Elsevier Scientific Publ. Company, Amsterdam, New York, Oxford, 243–260.
- Leonard A. and Leonard E.D., 1978.—Cytogenetic effects of myleran in vivo on bone marrow cells from male mice. Mutation Res., 56: 329–333.
- Li C.C., 1961.—Human genetics: principles and methods. McGraw Hill New York, 92.
- Matter B.E. and Tsuchimoto T., 1980.—Mutagenicity test system for the detection of chromosome aberration in vivo. Arch. Toxicol., 46: 89–98.
- Nordenson I., Beckman L. and Nordstrom S., 1977.—Occupational and environmental risks in and around smelter in northern Sweden. II. Chromosomal aberration in workers exposed to arsenic. Hereditas, 88: 47–50.
- Odashima S., 1976.—The cooperative development in Japan of methods for screening chemicals for carcinogenicity. IARC Sci. Publ. No. 12, (eds. R. Montesano, H. Bartsch, L. Tomatis and W. Davis), 61–79.
- Savage J.R.K., 1975.—Classification and relationships induced Chromosomal structural changes. J. Med. Gen., 12: 103–122.
- Tsuchimoto T., Matter B.E. and Deyssenroth H., 1979.—Analysis of chromosome aberrations and sister-chromatid exchanges in human lymphocytes exposed in vitro to hydergine. Mutation Res., 67: 39–45.
- Woodburry D.W., 1970.—Analgesics and antipyretics, anti-inflammatory agents and inhibitors of uric acid synthesis. In: «The Pharmacological basis of Therapeutics» (eds. L.B. Goodman and A. Gilman), Macmillian Co., London, 4.
- World Health Organisation Technical Report Series 482, 1971.—Evaluation and testing of drug? for mutagenicity: principles and problems. Geneva, 9–18.